In regard to Spampinato et al

We read the article by Spampinato et al. [1] focusing on the importance of ICRU bladder point (BP) dose on the incidence and persistence of urinary frequency and incontinence with great interest. The authors aimed to determine the patient- and treatment-related risk factors that may be associated with urinary frequency and incontinence by analyzing the patients with locally advanced cervical cancer (LACC) in the EMBRACE-I trial who underwent intracavitary brachytherapy (ICB) following chemoradiotherapy (CRT).

Source: Radiotherapy and Oncology - February 26, 2021 Category: Radiology Authors: Sezin Yuce Sar ı, Ecem Yıgıt, Melis Gultekın, Ferah Yıldı Source Type: research